AST 0 3 0 3 B-clinical_variable
( 4 5 4 5 I-clinical_variable
SGOT 5 9 5 9 I-clinical_variable
) 9 10 9 10 I-clinical_variable
≤ 11 12 11 12 O
2.0 13 16 13 16 B-upper_bound
times 17 22 17 22 I-upper_bound
ULN 23 26 23 26 I-upper_bound

Age 0 3 27 30 B-age
Requirement 4 15 31 42 O
≥ 16 17 43 44 O
18 18 20 45 47 B-lower_bound
years 21 26 48 53 I-lower_bound
of 27 29 54 56 O
age 30 33 57 60 B-age

ECOG 0 4 61 65 B-clinical_variable
Performance 5 16 66 77 I-clinical_variable
Status 17 23 78 84 I-clinical_variable
0 24 25 85 86 B-lower_bound
- 25 26 86 87 O
2 26 27 87 88 B-upper_bound

Failing 0 7 89 96 O
to 8 10 97 99 O
do 11 13 100 102 O
all 14 17 103 106 O
of 18 20 107 109 O
the 21 24 110 113 O
above 25 30 114 119 O
will 31 35 120 124 O
make 36 40 125 129 O
the 41 44 130 133 O
patient 45 52 134 141 O
NOT 53 56 142 145 O
eligible 57 65 146 154 O
for 66 69 155 158 O
CALGB 70 75 159 164 B-cancer
30610 76 81 165 170 I-cancer

Granulocytes 0 12 171 183 B-clinical_variable
≥ 13 14 184 185 O
1,500/µl 15 23 186 194 B-lower_bound

Histologically 0 14 195 209 O
or 15 17 210 212 O
cytologically 18 31 213 226 O
documented 32 42 227 237 O
small 43 48 238 243 B-cancer
cell 49 53 244 248 I-cancer
lung 54 58 249 253 I-cancer
cancer 59 65 254 260 I-cancer
( 66 67 261 262 I-cancer
SCLC 67 71 262 266 I-cancer
) 71 72 266 267 I-cancer

Limited 0 7 268 275 O
- 7 8 275 276 O
stage 8 13 276 281 O
disease 14 21 282 289 O
patients 22 30 290 298 O
with 31 35 299 303 O
disease 36 43 304 311 O
restricted 44 54 312 322 O
to 55 57 323 325 O
one 58 61 326 329 O
hemithorax 62 72 330 340 O
with 73 77 341 345 O
regional 78 86 346 354 B-cancer
lymph 87 92 355 360 I-cancer
node 93 97 361 365 I-cancer
metastases 98 108 366 376 I-cancer
, 108 109 376 377 O
including 110 119 378 387 O
ipsilateral 120 131 388 399 B-cancer
hilar 132 137 400 405 I-cancer
, 137 138 405 406 O
ipsilateral 139 150 407 418 B-cancer
and 151 154 419 422 I-cancer
contralateral 155 168 423 436 I-cancer
mediastinal 169 180 437 448 I-cancer
, 180 181 448 449 O
and 182 185 450 453 O
ipsilateral 186 197 454 465 B-cancer
supraclavicular 198 213 466 481 I-cancer
lymph 214 219 482 487 I-cancer
nodes 220 225 488 493 I-cancer

No 0 2 494 496 O
patients 3 11 497 505 O
that 12 16 506 510 O
are 17 20 511 514 O
known 21 26 515 520 O
to 27 29 521 523 O
be 30 32 524 526 O
pregnant 33 41 527 535 B-pregnancy
or 42 44 536 538 O
nursing 45 52 539 546 O

No 0 2 547 549 O
prior 3 8 550 555 O
mediastinal 9 20 556 567 B-treatment
or 21 23 568 570 I-treatment
thoracic 24 32 571 579 I-treatment
radiotherapy 33 45 580 592 I-treatment

No 0 2 593 595 O
prior 3 8 596 601 O
radiotherapy 9 21 602 614 B-treatment

Non 0 3 615 618 B-pregnancy
- 3 4 618 619 I-pregnancy
pregnant 4 12 619 627 I-pregnancy

Patients 0 8 628 636 O
may 9 12 637 640 O
have 13 17 641 645 O
received 18 26 646 654 O
one 27 30 655 658 O
and 31 34 659 662 O
only 35 39 663 667 O
one 40 43 668 671 O
cycle 44 49 672 677 O
of 50 52 678 680 O
chemotherapy 53 65 681 693 B-treatment
prior 66 71 694 699 I-treatment
to 72 74 700 702 O
enrolling 75 84 703 712 O
on 85 87 713 715 O
CALGB 88 93 716 721 B-treatment
30610 94 99 722 727 I-treatment
, 99 100 727 728 O
which 101 106 729 734 O
must 107 111 735 739 O
have 112 116 740 744 O
included 117 125 745 753 O
carboplatin 126 137 754 765 B-treatment
or 138 140 766 768 O
cisplatin 141 150 769 778 B-treatment
and 151 154 779 782 O
etoposide 155 164 783 792 B-treatment

Patients 0 8 793 801 O
must 9 13 802 806 O
have 14 18 807 811 O
measurable 19 29 812 822 O
disease 30 37 823 830 O
, 37 38 830 831 O
which 39 44 832 837 O
includes 45 53 838 846 O
lesions 54 61 847 854 O
that 62 66 855 859 O
can 67 70 860 863 O
be 71 73 864 866 O
accurately 74 84 867 877 O
measured 85 93 878 886 O
in 94 96 887 889 O
at 97 99 890 892 O
least 100 105 893 898 O
one 106 109 899 902 B-lower_bound
dimension 110 119 903 912 O
( 120 121 913 914 O
longest 121 128 914 921 O
diameter 129 137 922 930 O
to 138 140 931 933 O
be 141 143 934 936 O
recorded 144 152 937 945 O
) 152 153 945 946 O
as 154 156 947 949 O
≥ 157 158 950 951 O
2 159 160 952 953 B-lower_bound
cm 161 163 954 956 I-lower_bound
with 164 168 957 961 O
conventional 169 181 962 974 B-treatment
techniques 182 192 975 985 I-treatment
OR 193 195 986 988 O
≥ 196 197 989 990 O
1 198 199 991 992 B-lower_bound
cm 200 202 993 995 I-lower_bound
by 203 205 996 998 O
spiral 206 212 999 1005 B-treatment
CT 213 215 1006 1008 I-treatment
scan 216 220 1009 1013 I-treatment

Patients 0 8 1014 1022 O
with 9 13 1023 1027 O
complete 14 22 1028 1036 O
surgical 23 31 1037 1045 O
resection 32 41 1046 1055 B-treatment
of 42 44 1056 1058 O
disease 45 52 1059 1066 O
are 53 56 1067 1070 O
not 57 60 1071 1074 O
eligible 61 69 1075 1083 O

Patients 0 8 1084 1092 O
with 9 13 1093 1097 O
disease 14 21 1098 1105 O
involvement 22 33 1106 1117 O
of 34 36 1118 1120 O
the 37 40 1121 1124 O
contralateral 41 54 1125 1138 B-chronic_disease
hilar 55 60 1139 1144 I-chronic_disease
or 61 63 1145 1147 O
supraclavicular 64 79 1148 1163 B-chronic_disease
lymph 80 85 1164 1169 I-chronic_disease
nodes 86 91 1170 1175 I-chronic_disease
are 92 95 1176 1179 O
not 96 99 1180 1183 O
eligible 100 108 1184 1192 O

Patients 0 8 1193 1201 O
with 9 13 1202 1206 O
pleural 14 21 1207 1214 B-chronic_disease
effusions 22 31 1215 1224 I-chronic_disease
that 32 36 1225 1229 O
are 37 40 1230 1233 O
visible 41 48 1234 1241 O
on 49 51 1242 1244 O
plain 52 57 1245 1250 O
chest 58 63 1251 1256 O
radiographs 64 75 1257 1268 O
, 75 76 1268 1269 O
whether 77 84 1270 1277 O
cytologically 85 98 1278 1291 O
positive 99 107 1292 1300 O
or 108 110 1301 1303 O
not 111 114 1304 1307 O
are 115 118 1308 1311 O
not 119 122 1312 1315 O
eligible 123 131 1316 1324 O
unless 132 138 1325 1331 O
they 139 143 1332 1336 O
have 144 148 1337 1341 O
a 149 150 1342 1343 O
negative 151 159 1344 1352 O
thoracentesis 160 173 1353 1366 B-treatment

Platelet 0 8 1367 1375 B-clinical_variable
count 9 14 1376 1381 I-clinical_variable
≥ 15 16 1382 1383 O
100,000/µl 17 27 1384 1394 B-lower_bound

Registration 0 12 1395 1407 O
to 13 15 1408 1410 O
CALGB 16 21 1411 1416 B-treatment
30610 22 27 1417 1422 I-treatment
must 28 32 1423 1427 O
take 33 37 1428 1432 O
place 38 43 1433 1438 O
within 44 50 1439 1445 O
14 51 53 1446 1448 B-lower_bound
- 53 54 1448 1449 O
21 54 56 1449 1451 B-upper_bound
days 57 61 1452 1456 I-upper_bound
after 62 67 1457 1462 O
the 68 71 1463 1466 O
start 72 77 1467 1472 O
of 78 80 1473 1475 O
the 81 84 1476 1479 O
non 85 88 1480 1483 O
- 88 89 1483 1484 O
protocol 89 97 1484 1492 O
therapy 98 105 1493 1500 B-treatment

Serum 0 5 1501 1506 B-clinical_variable
creatinine 6 16 1507 1517 I-clinical_variable
≤ 17 18 1518 1519 O
1.5 19 22 1520 1523 B-upper_bound
times 23 28 1524 1529 I-upper_bound
ULN 29 32 1530 1533 I-upper_bound
OR 33 35 1534 1536 O
Calculated 36 46 1537 1547 B-clinical_variable
creatinine 47 57 1548 1558 I-clinical_variable
clearance 58 67 1559 1568 I-clinical_variable
≥ 68 69 1569 1570 O
70 70 72 1571 1573 B-lower_bound
mL 73 75 1574 1576 I-lower_bound
/ 75 76 1576 1577 I-lower_bound
min 76 79 1577 1580 I-lower_bound

Total 0 5 1581 1586 O
bilirubin 6 15 1587 1596 B-clinical_variable
≤ 16 17 1597 1598 O
1.5 18 21 1599 1602 B-upper_bound
times 22 27 1603 1608 I-upper_bound
upper 28 33 1609 1614 I-upper_bound
limit 34 39 1615 1620 I-upper_bound
of 40 42 1621 1623 I-upper_bound
normal 43 49 1624 1630 I-upper_bound
( 50 51 1631 1632 I-upper_bound
ULN 51 54 1632 1635 I-upper_bound
) 54 55 1635 1636 I-upper_bound

chemotherapy 0 12 1637 1649 B-treatment

patients 0 8 1650 1658 O
also 9 13 1659 1663 O
must 14 18 1664 1668 O
have 19 23 1669 1673 O
met 24 27 1674 1677 O
all 28 31 1678 1681 O
of 32 34 1682 1684 O
the 35 38 1685 1688 O
eligibility 39 50 1689 1700 O
criteria 51 59 1701 1709 O
in 60 62 1710 1712 O
the 63 66 1713 1716 O
protocol 67 75 1717 1725 O
prior 76 81 1726 1731 O
to 82 84 1732 1734 O
receiving 85 94 1735 1744 O
the 95 98 1745 1748 O
first 99 104 1749 1754 O
cycle 105 110 1755 1760 O
of 111 113 1761 1763 O
chemotherapy 114 126 1764 1776 B-treatment

